AAP’s Business Line

‘India Is A Very Key Market’

Getting The Formula Right

A few years ago, a doctor had doubts about the accuracy of the blood test report furnished by a neighbourhood pathology laboratory. He devised a test: he sent a sample containing red ink, marked as a patient’s blood sample. The report shocked him. It stated that the patient was hypothyroid as his thyroid stimulating hormone (TSH) level was above normal! Not only did the lab fail to detect that it was not a blood sample at all, it incorrectly diagnosed the condition of above-normal TSH as hypothyroidism when, actually, the diagnosis should have been hyperthyroidism.

A Mixed Bag

Indian Drug Cos To Counter MNC Pharma Lobby In US

Piramal’s Rs 20,000 Cr Gambit

Reddy To Experiment

‘Plan To Keep Ranbaxy Alive’

Most Top-selling Drugs In India Come From MNCs

Tirupur Knitwear Exports Cross Rs 13,000 Cr Mark

Old Cures, New Business

Uncle Sam’s Strong Medicine

Welspun Bets Big On Renewable Energy

Maharashtra, Punjab Try PPP Model In Diagnostic Facilities

Taking The Long Road